One of the mutations present in our patient’s tumor was a loss-of-function mutation in FAT1, which encodes a tumor suppressor proto cadherin involved in regulating several key pathways in cancer (40–42), including in sarcomas (43, 44). Here, CDH17 is linked to sarcoma.